Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Sep 2;13:976356. doi: 10.3389/fgene.2022.976356

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Ren, Wang, Zeng, Li, Chen, Peng, Bhawal and Guo.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Examination of the risk model in the CGGA training cohort. (A) Glioma samples in the CGGA were divided into low-risk or high-risk groups. (B) Kaplan-Meier plot analysis of the overall survival rate in low-risk and in high-risk patients with glioma in the CGGA. (C–E) Receiver operating characteristic (ROC) curves showing the diagnostic value of the risk model for the 1-year, 3-year and 5-year survival rates of patients with gliomas in the CGGA. (F) Survival time and status of each glioma patient in the CGGA cohort. (G) Expression levels of MYOD1, MMP9, SHOX2, WT1, HOXC6 and HOXA2 in glioma tissues from patients with high-risk or low-risk scores in the CGGA.